These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 19887821)
21. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome. Wu J; Zhu Y; Jiang Y; Cao Y Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522 [TBL] [Abstract][Full Text] [Related]
22. [Tyrosine phosphorylation and protein expression of insulin receptor substrate-1 in the patients with polycystic ovary syndrome]. Chu YL; Sun YY; Qiu HY; Li HF Zhonghua Fu Chan Ke Za Zhi; 2004 Mar; 39(3):176-9. PubMed ID: 15130378 [TBL] [Abstract][Full Text] [Related]
23. [Interrelationship of abnormal family history in the first degree relatives and clinical phenotype of patients with polycystic ovary syndrome]. Wang Y; Mao WW; Chen YJ; Li MZ; Qiao J; Wang LN Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):756-60. PubMed ID: 18307903 [TBL] [Abstract][Full Text] [Related]
24. [Comparison of HOMA IR with the minimal model for measuring insulin sensitivity in polycystic ovary syndrome]. Amador N; Espinoza G; Guízar JM; González M; Alpízar M Rev Invest Clin; 2001; 53(5):407-12. PubMed ID: 11795106 [TBL] [Abstract][Full Text] [Related]
25. Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome. Diamanti-Kandarakis E; Katsikis I; Piperi C; Alexandraki K; Panidis D Clin Endocrinol (Oxf); 2007 Jan; 66(1):103-9. PubMed ID: 17201808 [TBL] [Abstract][Full Text] [Related]
26. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in women with polycystic ovary syndrome. Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Cakir N; Arslan M Gynecol Endocrinol; 2006 Jun; 22(6):336-42. PubMed ID: 16785159 [TBL] [Abstract][Full Text] [Related]
27. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome. Barber TM; Wass JA; McCarthy MI; Franks S Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468 [TBL] [Abstract][Full Text] [Related]
28. Aquaglyceroporin-7 overexpression in women with the polycystic ovary syndrome. Seow KM; Lin YH; Wang PH; Hwang JL; Ho LT; Juan CC Gynecol Obstet Invest; 2013; 75(2):126-31. PubMed ID: 23235401 [TBL] [Abstract][Full Text] [Related]
29. Glucose intolerance in Japanese patients with polycystic ovary syndrome. Kurioka H; Takahashi K; Miyazaki K Arch Gynecol Obstet; 2007 Mar; 275(3):169-73. PubMed ID: 16972071 [TBL] [Abstract][Full Text] [Related]
30. [Tyrosine phosphorylation and protein expression of insulin receptor substrate-2 in the adipose tissue from patients with polycystic ovary syndrome]. Qiu HY; Chu YL; Li M; Sun YY; Li HF Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):116-9. PubMed ID: 15840293 [TBL] [Abstract][Full Text] [Related]
31. The relationship between metabolic status and levels of adiponectin and ghrelin in lean women with polycystic ovary syndrome. Bik W; Baranowska-Bik A; Wolinska-Witort E; Chmielowska M; Martynska L; Baranowska B Gynecol Endocrinol; 2007 Jun; 23(6):325-31. PubMed ID: 17616856 [TBL] [Abstract][Full Text] [Related]
32. Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome. Diamanti-Kandarakis E; Piperi C; Kalofoutis A; Creatsas G Clin Endocrinol (Oxf); 2005 Jan; 62(1):37-43. PubMed ID: 15638868 [TBL] [Abstract][Full Text] [Related]
33. Overexpression of the phosphoprotein enriched in diabetes gene product (Ped/pea-15) in women with polycystic ovary syndrome. Savastano S; Orio F; Palomba S; Cascella T; Manguso F; Lupoli GA; Formisano P; Lombardi G; Colao A; Beguinot F; Valentino R Clin Endocrinol (Oxf); 2007 Oct; 67(4):557-62. PubMed ID: 17590172 [TBL] [Abstract][Full Text] [Related]
34. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels. Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364 [TBL] [Abstract][Full Text] [Related]
35. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome. Yilmaz M; Bukan N; Ayvaz G; Karakoç A; Törüner F; Cakir N; Arslan M Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091 [TBL] [Abstract][Full Text] [Related]
36. Comparison of MRI-assessed body fat content between lean women with polycystic ovary syndrome (PCOS) and matched controls: less visceral fat with PCOS. Dolfing JG; Stassen CM; van Haard PM; Wolffenbuttel BH; Schweitzer DH Hum Reprod; 2011 Jun; 26(6):1495-500. PubMed ID: 21406446 [TBL] [Abstract][Full Text] [Related]
37. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome. Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948 [TBL] [Abstract][Full Text] [Related]
38. Retinol-binding protein in nonobese women with polycystic ovary syndrome. Lee JW; Im JA; Lee DC; Lee HR; Shim JY Clin Endocrinol (Oxf); 2008 May; 68(5):786-90. PubMed ID: 17986278 [TBL] [Abstract][Full Text] [Related]
39. No association of the G972S polymorphism of the insulin receptor substrate-1 gene with polycystic ovary syndrome in lean PCOS women with biochemical hyperandrogenemia. Marioli DJ; Koika V; Adonakis GL; Saltamavros AD; Karela A; Armeni AK; Tsapanos VS; Decavalas GO; Georgopoulos NA Arch Gynecol Obstet; 2010 Jun; 281(6):1045-9. PubMed ID: 20012307 [TBL] [Abstract][Full Text] [Related]
40. [Polymorphism in insulin receptor gene exon 17 in women with polycystic ovary syndrome]. Jin L; Huang HF; Jin F; Qian YL Zhonghua Fu Chan Ke Za Zhi; 2005 May; 40(5):323-6. PubMed ID: 15938783 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]